Drug & medication recalls

Genzyme Corporation recalls Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg…

Recall date
October 12, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0075-2018
FDA classification
Class III
Brand / firm
Genzyme Corporation
Sold / distributed
Nationwide

Why it was recalled

Labeling: Incorrect or Missing Package Insert.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.

Get recall alerts

Free email alert whenever Genzyme Corporation has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Genzyme Corporation